Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis

D. B. Scherf, H. Dally, P. Müller, G. Werle-Schneider, B. Jäger, L. Edler, S. Tuengerthal, J. R. Fischer, P. Drings, H. Bartsch, A. Risch
European Respiratory Journal 2010 35: 381-390; DOI: 10.1183/09031936.00125608
D. B. Scherf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Dally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Müller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Werle-Schneider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Jäger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Edler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Tuengerthal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. R. Fischer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Drings
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Bartsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Risch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The prognosis for lung cancer patients treated with chemotherapy is poor. Single nucleotide polymorphisms (SNPs) in matrix metalloproteinase (MMP) genes could influence treatment outcome by altering apoptotic pathways. Eight SNPs with known or suspected phenotypic effect in six genes (MMP1, MMP2, MMP3, MMP7, MMP9 and MMP12) were investigated.

For 349 Caucasian patients with primary lung cancer, receiving first-line chemotherapy, three different endpoints were analysed: response after the second cycle, progression free survival (PFS) and overall survival (OS).

The prognostic value of the SNPs was analysed using multiple logistic regression for all patients and histology-, stage- and treatment-specific subgroups. Hazard ratio estimates for PFS and OS were calculated using Cox regression methods.

None of the investigated polymorphisms modified response significantly in the whole patient population.

However, tumour stage IIIB variant allele carriers of MMP2 C-735T showed a significantly worse response. PFS was significantly prolonged in MMP1 G-1607GG variant allele carriers and OS in small cell lung cancer patients carrying the MMP12 A-82G variant allele.

In conclusion, this study identified SNPs in MMP1, MMP2, MMP7 and MMP12 for further investigation as possible predictors of chemotherapy outcome in lung cancer patients.

  • Apoptosis
  • lung cancer chemotherapy
  • matrix metalloproteinase
  • pharmacogenetics
  • polymorphism

Footnotes

    • © ERS Journals Ltd
    View Full Text
    PreviousNext
    Back to top
    View this article with LENS
    Vol 35 Issue 2 Table of Contents
    European Respiratory Journal: 35 (2)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    Print
    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis
    D. B. Scherf, H. Dally, P. Müller, G. Werle-Schneider, B. Jäger, L. Edler, S. Tuengerthal, J. R. Fischer, P. Drings, H. Bartsch, A. Risch
    European Respiratory Journal Feb 2010, 35 (2) 381-390; DOI: 10.1183/09031936.00125608

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis
    D. B. Scherf, H. Dally, P. Müller, G. Werle-Schneider, B. Jäger, L. Edler, S. Tuengerthal, J. R. Fischer, P. Drings, H. Bartsch, A. Risch
    European Respiratory Journal Feb 2010, 35 (2) 381-390; DOI: 10.1183/09031936.00125608
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • PATIENTS AND METHODS
      • RESULTS
      • DISCUSSION
      • Support statement
      • Statement of interest
      • Acknowledgments
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations
    • Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
    Show more Original Articles: Thoracic oncology

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • CME
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Submit a manuscript
    • ERS author centre

    For readers

    • Alerts
    • Subjects
    • Collections
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2019 by the European Respiratory Society